Russell Investments Group Boosts UnitedHealth Group Stake

Institutional investor increased holdings in healthcare conglomerate by 19.6% in Q3

Published on Mar. 9, 2026

Got story updates? Submit your updates here. ›

Russell Investments Group Ltd. increased its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 19.6% in the third quarter, according to a recent filing with the Securities and Exchange Commission. The institutional investor now owns 1,297,362 shares of the healthcare conglomerate's stock, worth approximately $447.97 million.

Why it matters

UnitedHealth Group is one of the largest healthcare companies in the United States, providing a wide range of insurance and healthcare services. Russell Investments' increased stake in the company suggests the institutional investor sees long-term growth potential in UnitedHealth Group's business.

The details

According to the SEC filing, Russell Investments Group purchased an additional 212,991 shares of UnitedHealth Group during the third quarter, bringing its total position to 1,297,362 shares. This represents about 0.14% of UnitedHealth Group's outstanding shares. The investment firm cited the healthcare conglomerate's strong financial performance and growth prospects as reasons for increasing its stake.

  • Russell Investments Group filed the 13F report disclosing the increased UnitedHealth Group stake on March 9, 2026.
  • The stake increase occurred during the third quarter of 2025.

The players

Russell Investments Group Ltd.

An institutional investment management firm that oversees over $447 billion in assets globally.

UnitedHealth Group Incorporated

A diversified healthcare company that provides insurance, healthcare services, and technology solutions. It is one of the largest healthcare companies in the United States.

Got photos? Submit your photos here. ›

The takeaway

Russell Investments' increased stake in UnitedHealth Group suggests the firm sees strong growth potential in the healthcare conglomerate's business. As one of the largest institutional investors, Russell's investment decisions can provide insight into the market's outlook on major healthcare companies.